만성구속스트레스 동물모델에 대한 JG02의 항우울 효과

키워드

참고문헌 (47)

1. The Korean Society of Oriental Neuropsychiatry Textbook Compilation Committee, "Oriental Neuropsychiatry" (2016), Jipmoondang
2. Korea Institute of Oriental Medicine, "Korean Medicine Clinical Practice Guideline of Depression" (2016), Elsevier Korea L.L.C.
3. The Survey of Mental Disorders in Korea in 2016, "Ministry of Health and Welfare", ~ (2016)
4. "Health Insurance Review and Assessment Service Medical Statistics Information"[URL]
5. The cause of death statistics, "Statistics korea", Statistics korea, ~ (2010)
6. Mass JW, "3-Methoxy-4-hy-droxyphenyl-glycol(MHPG) excretion in depressive states", Arch.Gen.Psychiatry, 19, pp.129~134 (1968)
7. Goodwin FK, "5-HT and nor-epinephrine "subgroups" in depression. Metabolites find-ings and clinical pharmacological correlation", Sci.Proc. Am.Psychiatr.Assoc, 130, pp.108~131 (1977)
8. Bouvier, N., "Development of an-tidepressant drugs. Experience and prospects", Presse Med, 32(11), pp.519~522 (2003)
9. Min SG, "Latest psychiatry" (2006), Iljokak
10. Lee MS, "Pharmacological Treatment of Depression", Journal of the Korean Medical Association, 46(1), pp.69~75 (2003)
11. Park WM, "Clinical Neuropsychopharmacology" (2014), SigmaPress
12. The Korean Neuropsychiatric Association, "Textbook of neuropsychiatry" (2017), iMiS Company
13. Lee JS, "Management issues in new antidepressant side effects", Korean J Psychopharmacol, 10(Suppl 1), pp.35~47 (1999)
14. Yun HY, "Bupleurum falcatum prevents depression and anxiety-like behaviors in the rats exposed to repeated re-straint stress", Master, pp.2012
15. Kang HW, "A Study on The Oriental-medical Understanding of De-pression", J of Oriental Neuropsychiatry, 12(2), pp.1~15 (2001)
16. Heo J, "Donguibogam", pp.1382~1386 (2006), Donguibogam Pub-lishing House
17. The Textbook Compilation Committee of Herbalogy of Oriental Medical Schools in Nation, "Herbalogy" (2016), Younglim Publisher
18. 이은희, "우울증 변증도구 개발을 위한 기초연구", 동의신경정신과학회지, 24(4), pp.435~450 (2013), 대한한방신경정신과학회
19. 이헌수, "우울증 변증도구의 신뢰도, 타당도 평가", 동의신경정신과학회지, 26(4), pp.407~416 (2015), 대한한방신경정신과학회
20. 장문규, "附子의 우울증 억제효과에 관한 연구", 동의신경정신과학회지, 20(3), pp.49~64 (2009), 대한한방신경정신과학회
21. 이진우, "연자육의 항우울 효과 및 프로티옴 분석을 통한 기전 연구", 동의생리병리학회지, 20(4), pp.830~843 (2006), 한의병리학회
22. 민남기, "赤芍藥이 강제수영부하시험에서 CRF, c-Fos 와 TH에 미치는 영향", 대한본초학회지, 25(4), pp.61~67 (2010), 대한본초학회
23. 권용욱, "靑皮가 강제수영부하에 따른 우울행동에 미치는 영향", 대한본초학회지, 23(4), pp.59~70 (2008), 대한본초학회
24. 심은영, "地骨皮와 牧丹皮 複合劑가 강제수영부하실험에서 CRF, c-Fos와 Tyrosine Hydroxylase에 미치는 영향", 대한본초학회지, 26(2), pp.59~66 (2011), 대한본초학회
25. Lee DK, "Antidepressant effect of Licium chinense Mill. and its influence on serotonin and its metabolite of depression model rats", Herbal Formula Science, 11(2), pp.185~196 (2004)
26. Kim IJ, "Experimental Study on the Antidepres-sant Effect of Ginseng Radix Alba and Cyperi Rhizoma", J of Oriental Neuropsychiatry, 15(1), pp.101~119 (2004)
27. Seong WY, "The Effects of Quibitang in the Chronic Mild Stress Model of Depression in Rats", J of Oriental Neuropsychiatry, 13(2), pp.121~147 (2002)
28. Ryu JM, "The effects of Jowiseungchungtang versus fluoxetine in the chronic mild stress model of depression in rats", J of Oriental Neuropsychiatry, 15(1), pp.27~41 (2004)
29. 임재원, "分心氣飮加味方의 항산화능과 serotonin 대사에 미치는 영향", 동의신경정신과학회지, 22(2), pp.147~162 (2011), 대한한방신경정신과학회
30. 심태경, "加味逍遙散의 항산화 효과와 serotonin 대사과정에 미치는 영향", 동의신경정신과학회지, 22(1), pp.37~51 (2011), 대한한방신경정신과학회
31. Porsolt RD, "Behavioural de-spair in rats: A new model sensitive to antidepressant treatments", European Journal of Pharmacology, 47, pp.379~391 (1978)
32. Choi KM, "Chronic immobilization stress induces anxiety- and depression-like behaviors and decreases transthyretin in the mouse cortex", Neuro-science Letters, 461(2), pp.121~125 (2009)
33. Woo YS, "Treatment of Depression", Kor J Medicine, 70(2), pp.239~242 (2005)
34. Textbook of depressive disorder, "Korean society for de-pressive and bipolar disorders" (2012), Sigma-press
35. Lee SH, "A Case of Mixed Anxiety and Depressive Disorder", J of Oriental Neuropsychiatry, 14(2), pp.127~134 (2003)
36. 이진희, "봉독이 우울증 모델 흰쥐에게 미치는 영향", 동의신경정신과학회지, 21(2), pp.61~73 (2010), 대한한방신경정신과학회
37. Murer MG, "Brain-derived neu-rotrophic factor in the control human brain, and in Alzheimer’s disease and Par�kinson’s disease", Prog Neurobiol, 63, pp.71~124 (2001)
38. Duman RS, "Neuronal plasticity and survival in mood disorders", Biol Psychiatry, 48, pp.732~739 (2000)
39. Shimizu E, "Alterations of serum levels of brain-de-rived neurotrophic factor (BDNF) in depressed patients with or without antidepressants", Biol Psychiatry, 54, pp.70~75 (2003)
40. Nibuya M, "Repeat-ed stress increases catalytic TrkB mRNA in rat hippo-campus", Neurosci Lett, 267, pp.81~84 (1999)
41. Smith MA, "Stress in-creases brain-derived neurotropic factor messenger ri-bonucleic acid in the hypothalamus and pituitary", Endo-crinology, 136, pp.3743~3750 (1995)
42. Smith MA, "Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus", J Neurosci, 15, pp.1768~1777 (1995)
43. Lee YM, "Association Study Between Brain-Derived Neurotrophic Factor Genetic Polymorphism and Treat-ment Responses of Selective Serotonin Reuptake Inhibitor in Major Depressive Disorder", J Korean Geriatric Psy-chiatry, 12, pp.34~39 (2008)
44. Nibuya M, "Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antide�pressant drug treatments", J Neuro-sci, 15, pp.7539~7547 (1995)
45. Nibuya M, "Chronic antidepres-sant admini�stration increases the expression of cAMP response element binding protein (CREB) in rat hippo-campus", J Neurosci, 16, pp.2365~2372 (1996)
46. Russo-Neustadt A, "Exercise, an-tidepressant medications, and enhanced brain derived neurotrophic factor expression", Neuropsychopharmaco-logy, 21, pp.679~682 (1999)
47. 김용구, "미래의 세로토닌성 약물의 전망 및 임상적 유용성", 대한정신약물학회지, 17(3), pp.273~282 (2006), 대한정신약물학회

관련 논문AI추천